HealthManagement, Volume 2 - Issue 2, Winter 2008

Physio-Control, a wholly owned subsidiary of Medtronic Inc. received clearance from the FDA on October 3, 2008 to market the LIFEPAK 20e defibrillator / monitor within the US. It is an enhancement of the LIFEPAK 20 with a more powerful lithium-ion battery doubling ECG monitoring time. It is a non-evasive way to monitor the oxygenisation of a patient’s haemoglobin and has been developed so it can be easily transported helping hospitals meet JCAHO standards for having resuscitation services readily available in all facility areas.

«« Study Proves Smoking Ban Effective


Abbott Begins U.S. Study Drug Eluting Stent Designed for Small Vessels »»